Data / Research funding / Neurosciences
Neurosciences: 37,502 NIH awards ($49.6B) to 1,886 organizations
37,502 NIH awards ($49.6B) in the NIH spending category Neurosciences, to 1,886 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 37,502 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Health and Retirement Study: Yrs 35-40 | NIH | National Institute on Aging | 2021 to 2025 | $142,220,153 | September 25, 1990 | December 31, 2029 | WEIR, DAVID R. | reporter.nih.gov |
| COG NCTN Year 12 BIQSFP Progress Report | NIH | National Cancer Institute | 2021 to 2025 | $141,250,012 | April 11, 2014 | February 28, 2026 | HAWKINS, DOUGLAS S. | reporter.nih.gov |
| Alzheimer's Clinical Trials Consortium (ACTC) | NIH | National Institute on Aging | 2021 to 2025 | $119,771,576 | December 2, 2017 | August 31, 2028 | AISEN, PAUL S. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) | NIH | National Institute on Aging | 2021 to 2025 | $82,684,947 | September 30, 2020 | August 31, 2026 | HANDEN, BENJAMIN L | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| Functionally guided adult whole brain cell atlas in human and NHP | NIH | National Institute of Mental Health | 2022 to 2025 | $75,056,208 | August 22, 2022 | June 30, 2027 | LEIN, ED | reporter.nih.gov |
| Center for Multiomic Human Brain Cell Atlas | NIH | National Institute of Mental Health | 2022 to 2025 | $74,756,329 | September 1, 2022 | June 30, 2027 | ECKER, JOSEPH R | reporter.nih.gov |
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $71,153,847 | September 18, 2020 | July 31, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | NIH | National Institute on Aging | 2021 to 2025 | $65,403,220 | July 15, 2002 | May 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| The National Health and Aging Trends Study and National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2025 | $65,386,641 | September 30, 2008 | March 31, 2029 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| ProNET: Psychosis-Risk Outcomes Network | NIH | National Institute of Mental Health | 2021 to 2025 | $61,984,741 | September 8, 2020 | May 31, 2026 | WOODS, SCOTT W | reporter.nih.gov |
| The Alzheimer's Disease Tau Platform Clinical Trial | NIH | National Institute on Aging | 2023 to 2024 | $60,700,604 | September 21, 2023 | August 31, 2028 | BOXER, ADAM L. | reporter.nih.gov |
| ADRC Consortium for Clarity in ADRD Research Through Imaging | NIH | National Institute on Aging | 2023 to 2024 | $60,357,563 | September 15, 2023 | August 31, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| Emory National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $59,605,748 | May 1, 1997 | April 30, 2026 | LEE, JOON SUP | reporter.nih.gov |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) | NIH | National Institute on Aging | 2021 to 2025 | $56,766,232 | September 15, 2019 | August 31, 2030 | BOEVE, BRADLEY F | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| An Atlas of Human Brain Cell Variation | NIH | National Institute of Mental Health | 2022 to 2025 | $54,214,022 | September 13, 2022 | June 30, 2027 | MCCARROLL, STEVEN ANDREW | reporter.nih.gov |
| Yale Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $53,543,083 | July 1, 2016 | March 31, 2027 | SMITH, BRIAN RICHARD | reporter.nih.gov |
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| Access for All in ALS (ALL ALS) East Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $49,098,369 | September 25, 2023 | June 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias. | NIH | National Institute on Aging | 2021 to 2025 | $48,445,852 | March 1, 2020 | August 31, 2030 | LEIN, ED | reporter.nih.gov |
| National Alzheimer's Coordinating Center | NIH | National Institute on Aging | 2021 to 2025 | $45,845,722 | June 15, 2021 | May 31, 2027 | STEPHENS, KARI A | reporter.nih.gov |
| IU/JAX/PITT MODEL-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $45,129,948 | September 30, 2016 | August 31, 2027 | LAMB, BRUCE T | reporter.nih.gov |
| NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $43,417,361 | March 1, 2025 | February 28, 2032 | TRIVEDI, MADHUKAR H. | reporter.nih.gov |
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Longitudinal multicenter head-to-head harmonization of tau PET tracers | NIH | National Institute on Aging | 2021 to 2025 | $41,111,092 | September 1, 2021 | May 31, 2027 | PASCOAL, THARICK | reporter.nih.gov |
| UC Irvine MODEL-AD | NIH | National Institute on Aging | 2021 to 2025 | $40,119,354 | September 15, 2017 | August 31, 2027 | LAFERLA, FRANK M | reporter.nih.gov |
| Color's software-powered, high-touch delivery of genetic counseling sessions and pharmacogenomics consultations for return of genomic results | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $39,709,604 | August 20, 2019 | September 19, 2024 | TOPPER, SCOTT | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD) | NIH | National Institute on Aging | 2021 to 2025 | $39,317,019 | September 15, 2018 | February 29, 2028 | ASTHANA, SANJAY | reporter.nih.gov |
| Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium | NIH | National Institute on Aging | 2021 to 2025 | $37,497,984 | September 30, 2021 | August 31, 2026 | HOHMAN, TIMOTHY J | reporter.nih.gov |
| Cognitive training to reduce incidence of cognitive impairment in older adults | NIH | National Institute on Aging | 2021 to 2024 | $37,326,564 | February 1, 2021 | January 31, 2027 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| The Healthy Brain and Child Development National Consortium Administrative Core | NIH | National Institute on Drug Abuse | 2021 to 2025 | $37,142,240 | September 30, 2021 | June 30, 2026 | CHAMBERS, CHRISTINA | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE NHLBI FUNDING FROM THE WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $36,880,325 | February 1, 2021 | January 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| Health and Aging Brain among Latino Elders (HABLE-AT(N)) Study | NIH | National Institute on Aging | 2021 to 2025 | $36,277,689 | August 1, 2020 | April 30, 2027 | O'BRYANT, SID E | reporter.nih.gov |
| Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study | NIH | National Institute on Aging | 2021 to 2024 | $36,190,244 | August 15, 2020 | May 31, 2025 | ABUSHAKRA, SUSAN | reporter.nih.gov |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD) | NIH | National Institute on Aging | 2021 to 2025 | $35,388,433 | March 1, 2021 | May 31, 2026 | KIND, AMY J. | reporter.nih.gov |
| The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $35,158,235 | February 15, 2021 | January 31, 2027 | LAH, JAMES J | reporter.nih.gov |
| NeuroTech Harbor: Seedling Cohort 3 | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $35,143,434 | September 30, 2022 | June 30, 2027 | SARMA, SRIDEVI V. | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Combination anti-amyloid therapy for preclinical Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $34,903,050 | September 30, 2018 | May 31, 2025 | AISEN, PAUL S. | reporter.nih.gov |
| TARGET ENGAGEMENT OF INVESTIGATIONAL AGENTS IN PSPP | NIH | National Institute on Drug Abuse | 2021 to 2023 | $34,631,197 | September 15, 2023 | September 14, 2024 | GHAVAMI, AFSHIN | reporter.nih.gov |
| A Next Generation Data Infrastructure to Understand Disparities across the Life Course | NIH | National Institute on Aging | 2023 to 2025 | $34,372,705 | August 15, 2023 | July 31, 2028 | KAPTEYN, ARIE | reporter.nih.gov |
| Pediatric Eye Disease Investigator Group Coordinating Center | NIH | National Eye Institute | 2021 to 2025 | $33,066,572 | May 1, 1997 | December 31, 2028 | KRAKER, RAYMOND | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2024 to 2025 | $32,776,590 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| Early Onset AD Consortium - the LEAD Study (LEADS) | NIH | National Institute on Aging | 2021 to 2023 | $31,594,379 | September 30, 2018 | May 31, 2025 | APOSTOLOVA, LIANA G | reporter.nih.gov |
| ProCAN: Psychosis Risk Outcomes Compound Assessment Network | NIH | National Institute of Mental Health | 2024 to 2025 | $31,583,752 | June 14, 2024 | May 31, 2029 | WOODS, SCOTT W | reporter.nih.gov |
| Children's Oncology Group | NIH | National Cancer Institute | 2023 to 2025 | $31,354,180 | March 1, 2023 | February 28, 2026 | ALONZO, TODD A | reporter.nih.gov |
| IUSM TREAT-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $31,208,587 | September 30, 2019 | November 30, 2029 | PALKOWITZ, ALAN D. | reporter.nih.gov |
| Healthy Brain and Child Development National Consortium Data Coordinating Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $30,320,471 | September 30, 2021 | June 30, 2026 | SMYSER, CHRISTOPHER DANIEL | reporter.nih.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $29,083,069 | August 16, 2021 | April 30, 2027 | MONTANER, LUIS J | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $28,395,368 | September 1, 2022 | August 31, 2027 | SILVA, AFONSO C | reporter.nih.gov |
| An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $27,895,551 | September 25, 2023 | August 31, 2027 | PAGANONI, SABRINA | reporter.nih.gov |
| Bridge Funding for Dominantly Inherited Alzheimer Network | NIH | National Institute on Aging | 2021 to 2025 | $27,724,157 | September 15, 2008 | June 30, 2026 | BATEMAN, RANDALL J | reporter.nih.gov |
| Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant | NIH | National Cancer Institute | 2021 to 2025 | $27,607,459 | June 1, 2025 | July 31, 2026 | ROTH, MICHAEL E. | reporter.nih.gov |
| RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 2 - COMMERCIALIZATION CENTER - HEAL | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $27,543,152 | June 2, 2025 | June 1, 2026 | reporter.nih.gov | |
| REACH: Research Enterprise to Advance a Cure for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,533,114 | August 16, 2021 | April 30, 2027 | JONES, R. BRAD | reporter.nih.gov |
| Comprehensive single-cell atlas of the developing mouse brain | NIH | National Institute of Mental Health | 2022 to 2025 | $27,074,849 | September 1, 2022 | June 30, 2027 | ARLOTTA, PAOLA | reporter.nih.gov |
| Delaney AIDS Research Enterprise to Cure HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,967,938 | August 16, 2021 | April 30, 2027 | DEEKS, STEVEN GRANT | reporter.nih.gov |
| Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $26,536,563 | September 1, 2021 | May 31, 2028 | HOH, BRIAN LIM | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Collaboratory of AIDS Researchers for Eradication (CARE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,234,170 | August 16, 2021 | April 30, 2027 | MARGOLIS, DAVID M. | reporter.nih.gov |
| BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $25,707,343 | December 9, 2024 | June 8, 2026 | MICHELS, PETER C | reporter.nih.gov |
| ERASE HIV: Enterprise for Research and Advancements to Stop and Eradicate HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $25,334,968 | August 16, 2021 | June 12, 2026 | PAIARDINI, MIRKO | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| ASPirin in Reducing Events in the Elderly - eXTension | NIH | National Institute on Aging | 2021 to 2023 | $24,851,437 | July 15, 2019 | April 30, 2026 | MURRAY, ANNE M | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia | NIH | National Institute on Aging | 2021 to 2024 | $24,586,693 | September 15, 2020 | May 31, 2026 | FARRER, LINDSAY A. | reporter.nih.gov |
| Center without Walls for Imaging Proteinopathies with PET | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $24,457,384 | September 24, 2019 | July 31, 2029 | MACH, ROBERT H | reporter.nih.gov |
| Asian Cohort for Alzheimer's Disease (ACAD) | NIH | National Institute on Aging | 2023 to 2025 | $24,263,451 | July 1, 2023 | June 30, 2028 | WANG, LI-SAN | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | NIH | National Institute of Mental Health | 2021 to 2025 | $24,090,655 | September 8, 2020 | May 31, 2026 | NELSON, CHRISTOPHER BARNABY | reporter.nih.gov |
| Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,837,604 | April 9, 2019 | September 30, 2026 | GANGE, STEPHEN J | reporter.nih.gov |
| Integrating Information about Aging Surveys: Novel Integration of Contextual Data to Study Late-Life Cognition and Alzheimer’s Disease and Related Dementia and Dementia Care | NIH | National Institute on Aging | 2021 to 2025 | $23,672,206 | May 1, 2007 | March 31, 2027 | LEE, JINKOOK | reporter.nih.gov |
| Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study | NIH | National Institute on Aging | 2021 to 2024 | $23,438,396 | May 15, 2019 | December 31, 2025 | SPERLING, REISA A. | reporter.nih.gov |
| Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $23,431,388 | August 15, 2021 | July 31, 2027 | MUCKE, LENNART | reporter.nih.gov |
| I4C 2.0: Immunotherapy for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,329,181 | August 16, 2021 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| SF Bay Area MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,128,905 | April 1, 2019 | September 30, 2026 | TIEN, PHYLLIS C | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO) | NIH | National Institute on Aging | 2021 to 2025 | $23,099,141 | September 30, 2021 | August 31, 2027 | PERLS, THOMAS T | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $22,785,879 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Mount Sinai ECHO site for Perinatal Environment and Development Studies | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $22,671,567 | September 21, 2016 | May 31, 2030 | WRIGHT, ROSALIND J | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | NIH | National Institute on Aging | 2021 to 2025 | $21,982,300 | April 1, 2012 | April 30, 2027 | WANG, LI-SAN | reporter.nih.gov |
| REVEAL - Research Evaluating Vagal Excitation and Anatomical Linkages. | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $21,646,919 | September 23, 2022 | August 31, 2025 | OSBORN, JOHN W | reporter.nih.gov |
| Wisconsin Registry for Alzheimer's Prevention | NIH | National Institute on Aging | 2023 to 2025 | $21,491,270 | June 1, 2023 | February 29, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $21,489,807 | September 8, 2023 | August 31, 2028 | LICHTMAN, JEFF W | reporter.nih.gov |
| APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $21,355,638 | September 30, 2020 | March 31, 2027 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $21,254,211 | September 6, 2024 | September 5, 2026 | HANANIA, TALEEN | reporter.nih.gov |
| Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease | NIH | National Institute on Aging | 2021 to 2025 | $21,188,740 | September 30, 2021 | August 31, 2027 | PAULSEN, JANE S | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| A Strategy for Heal Federated Data Ecosystem | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $21,063,286 | February 18, 2021 | April 30, 2026 | GOSWAMI, SUPARNA | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,023,937 | April 1, 2019 | September 30, 2026 | SHARMA, ANJALI | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| ABCD-USA Consortium: Data Analysis, Informatics and Resource Center | NIH | National Institute on Drug Abuse | 2021 to 2024 | $20,902,844 | September 30, 2015 | March 31, 2025 | DALE, ANDERS M | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $20,858,598 | March 23, 2022 | December 31, 2025 | WILCOX, KAREN | reporter.nih.gov |
| Alzheimer's Gut Microbiome Project | NIH | National Institute on Aging | 2021 to 2023 | $20,743,566 | September 15, 2019 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-Old | NIH | National Institute on Aging | 2022 to 2025 | $20,680,832 | September 15, 2017 | June 30, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative | NIH | National Institute on Aging | 2022 to 2024 | $20,575,729 | September 1, 2022 | August 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| A Multidisciplinary Center for Developing Human and Non-human Primate Brain Cell Atlases | NIH | National Institute of Mental Health | 2022 to 2025 | $20,505,732 | September 16, 2022 | June 30, 2027 | KRIEGSTEIN, ARNOLD | reporter.nih.gov |
| Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $20,420,182 | September 30, 2013 | August 31, 2028 | KRISHNAN-SARIN, SUCHITRA | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| Einstein Aging Study | NIH | National Institute on Aging | 2021 to 2024 | $20,102,748 | September 29, 1982 | March 31, 2028 | DERBY, CAROL A. | reporter.nih.gov |
| South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,943,827 | September 30, 2001 | August 31, 2026 | GOLDSMITH, EDIE C | reporter.nih.gov |
| Massachusetts Alzheimer's Disease Research Center (MADRC) | NIH | National Institute on Aging | 2021 to 2025 | $19,915,545 | May 15, 2019 | March 31, 2029 | GOMEZ-ISLA, TERESA | reporter.nih.gov |
| National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS) | NIH | National Institute on Aging | 2021 to 2025 | $19,881,397 | August 1, 2017 | April 30, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| Oxytocin Modulation of Neural Circuit Function and Behavior | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,624,247 | September 15, 2018 | July 31, 2028 | TSIEN, RICHARD W | reporter.nih.gov |
| EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,316,294 | January 1, 2021 | July 31, 2026 | FAVA, MAURIZIO | reporter.nih.gov |
| Oklahoma IDeA Network of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,194,069 | September 6, 2001 | August 31, 2030 | LANG, MARK L | reporter.nih.gov |
| UCSD Shiley-Marcos Alzheimer's Disease Research Center P30 | NIH | National Institute on Aging | 2021 to 2025 | $18,959,959 | May 1, 2019 | March 31, 2029 | BREWER, JAMES B | reporter.nih.gov |
| JCOIN Phase II Coordination and Translation Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,785,790 | September 30, 2019 | May 31, 2029 | TAXMAN, FAYE S | reporter.nih.gov |
| Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI) | NIH | National Institute on Aging | 2021 to 2025 | $18,706,904 | September 15, 2013 | May 31, 2028 | BERKMAN, LISA F | reporter.nih.gov |
| Mississippi Center for Clinical and Translational Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $18,674,548 | August 18, 2016 | July 31, 2026 | GRANGER, JOEY P. | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $18,523,030 | August 15, 2023 | July 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| Mayo Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $18,486,241 | July 1, 2019 | April 30, 2029 | BOEVE, BRADLEY F | reporter.nih.gov |
| BRAIN CONNECTS: Center for a pipeline of high throughput integrated volumetric electron microscopy for whole mouse brain connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $18,402,104 | September 1, 2023 | August 31, 2028 | MACARICO DA COSTA, NUNO | reporter.nih.gov |
| State-dependent Decision-making in Brainwide Neural Circuits | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $18,155,129 | August 15, 2021 | July 31, 2027 | PANINSKI, LIAM M | reporter.nih.gov |
| An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $18,136,504 | September 28, 2022 | August 31, 2025 | PAGANONI, SABRINA | reporter.nih.gov |
| Lifecourse health, cerebral pathology and differences in dementia risk (KHANDLE Study) | NIH | National Institute on Aging | 2021 to 2025 | $18,022,067 | June 1, 2016 | February 28, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $17,997,906 | May 15, 2022 | January 31, 2028 | GONZALEZ, HECTOR M | reporter.nih.gov |
| Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $17,995,278 | September 1, 2022 | November 30, 2026 | BENSOUSSAN, YAEL EMILIE | reporter.nih.gov |
| The Heart and the Mind: An Integrative Approach to Brain-Body Interactions in the Zebrafish | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $17,898,597 | September 25, 2017 | August 31, 2027 | ENGERT, FLORIAN | reporter.nih.gov |
| Mount Sinai Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,735,870 | May 1, 2020 | March 31, 2030 | SANO, MARY | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2021 to 2024 | $17,711,217 | September 1, 2019 | August 31, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| UNSPECIFIED [23-005143] | NIH | National Institute on Drug Abuse | 2023 to 2025 | $17,674,438 | May 29, 2023 | May 28, 2026 | GERMER, SOREN | reporter.nih.gov |
| Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP) | NIH | National Institute on Aging | 2021 to 2024 | $17,661,924 | July 1, 2020 | June 30, 2026 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,255,961 | June 15, 2020 | April 30, 2030 | SMALL, SCOTT A | reporter.nih.gov |
| Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal) | NIH | National Institute on Aging | 2021 to 2025 | $17,112,209 | August 15, 2018 | May 31, 2029 | HUGHES, TIMOTHY M. | reporter.nih.gov |
| Offspring Study of Mechanisms for Racial Disparities in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $17,095,138 | September 1, 2016 | May 31, 2027 | MANLY, JENNIFER JAIE | reporter.nih.gov |
| NORTHWESTERN Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,093,229 | August 15, 2021 | June 30, 2026 | VASSAR, ROBERT J | reporter.nih.gov |
| Replication Study of Off-Target Assays for Guide RNAs in CRISPR-Based Therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,077,732 | December 1, 2024 | April 30, 2025 | SAHA, KRISHANU | reporter.nih.gov |
| Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 to 2025 | $17,073,728 | September 1, 2022 | June 30, 2027 | NORRIS, CHRISTOPHER MARK | reporter.nih.gov |
| Point of Care Technology Research Center in Primary Care - ITAP | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $17,069,569 | April 1, 2022 | September 30, 2023 | PARRISH, JOHN A | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| Goizueta Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $16,684,611 | July 15, 2020 | April 30, 2030 | LEVEY, ALLAN I | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $16,489,352 | September 15, 2021 | August 31, 2028 | MOLER, FRANK W | reporter.nih.gov |
| 8/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT CHLA | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,425,086 | September 30, 2015 | July 31, 2026 | SOWELL, ELIZABETH R | reporter.nih.gov |
| Diabetes and brain amyloid in middle aged Hispanics | NIH | National Institute on Aging | 2021 to 2025 | $16,383,484 | September 1, 2015 | May 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Round 5 | NIH | National Institute on Aging | 2021 to 2025 | $16,330,170 | September 15, 2014 | April 30, 2029 | WAITE, LINDA J | reporter.nih.gov |
| University of Kansas Alzheimer's Disease Research Center (KU ADRC) | NIH | National Institute on Aging | 2021 to 2025 | $16,309,323 | August 15, 2021 | June 30, 2026 | SWERDLOW, RUSSELL H. | reporter.nih.gov |
| Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $16,244,011 | September 24, 2001 | August 31, 2026 | JUDD, SUZANNE E | reporter.nih.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia Project | NIH | National Institute on Aging | 2021 to 2025 | $16,156,406 | January 15, 2021 | December 31, 2026 | HUMMER, ROBERT A | reporter.nih.gov |
| Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $16,136,344 | March 15, 2014 | August 31, 2026 | BROTT, THOMAS G | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| Alzheimer's Disease Genetics Consortium | NIH | National Institute on Aging | 2021 to 2024 | $15,948,152 | April 1, 2009 | March 31, 2026 | SCHELLENBERG, GERARD DAVID | reporter.nih.gov |
| Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $15,805,224 | July 1, 2018 | November 30, 2025 | BARSAN, WILLIAM G | reporter.nih.gov |
| RECONSTRUCTING VAGAL ANATOMY | NIH | Office of the Director, National Institutes of Health | 2022 to 2024 | $15,790,088 | September 21, 2022 | September 20, 2025 | SHOFFSTALL, ANDREW | reporter.nih.gov |
| Arizona Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $15,728,435 | September 5, 2021 | June 30, 2027 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2021 to 2022 | $15,706,591 | May 15, 2019 | February 29, 2024 | WARREN, JOHN ROBERT | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,682,941 | July 7, 2010 | March 31, 2024 | CORESH, JOSEF | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,678,563 | April 1, 2019 | September 30, 2026 | FRENCH, AUDREY | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Therapeutic Editing to Lower PrP in Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $15,507,691 | May 17, 2023 | April 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| Clarifying the Optimal Application of SLT Therapy (COAST) Trial | NIH | National Eye Institute | 2021 to 2024 | $15,288,624 | September 30, 2020 | August 31, 2025 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4) | NIH | National Institute on Aging | 2021 to 2024 | $15,274,483 | September 1, 2015 | March 31, 2026 | PANIZZON, MATTHEW S | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,081,381 | April 1, 2019 | September 30, 2026 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,990,990 | August 1, 2008 | June 30, 2030 | DIAMOND, BETTY | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,887,505 | March 1, 2025 | August 31, 2025 | CUDKOWICZ, MERIT E | reporter.nih.gov |
| BIOLOGICS IDIQ TASK ORDER- NON-GLP TOXICITY AND TOXICOKINETIC STUDIES IN RODENTS AND NON-RODENTS FOR A NOVEL, SUBCUTANEOUSLY-DOSED MODIFIED-HEPARIN DRUG | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,836,664 | September 29, 2025 | September 28, 2026 | reporter.nih.gov | |
| TASK AREAS TWO (2), THREE (3), FOUR (4), AND SIX (6)FOR THE NATIONAL INSTITUTE OF HEALTH (NIH) BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES (BRAIN) INITIATIVE CELL ATLAS NETWORK (BIC | NIH | National Institute on Drug Abuse | 2023 to 2025 | $14,810,400 | May 29, 2023 | May 28, 2026 | GABRIEL, STACEY | reporter.nih.gov |
| NIH NATIONAL BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,799,056 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Child Neurologist Career Development Program | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,787,372 | August 15, 2016 | July 31, 2027 | SCHLAGGAR, BRADLEY L | reporter.nih.gov |
| English Longitudinal Study of Ageing - Renewal 2024 | NIH | National Institute on Aging | 2021 to 2025 | $14,720,227 | September 30, 2000 | May 31, 2029 | STEPTOE, ANDREW | reporter.nih.gov |
| Alzheimer's Disease Research Centers | NIH | National Institute on Aging | 2021 to 2025 | $14,719,450 | September 1, 2020 | March 31, 2030 | CHUI, HELENA CHANG | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $14,684,279 | August 1, 2001 | July 31, 2028 | BARNATO, AMBER E | reporter.nih.gov |
| Prenatal and Early Childhood Pathways To Health: An Integrated Model of Chemical and Social Exposures, Biological Mechanisms, and Sex-Specific Effects on Neurodevelopment and Respiratory Outcomes | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $14,672,582 | September 21, 2016 | August 31, 2025 | KARR, CATHERINE J | reporter.nih.gov |
| Alzheimer's Disease Research Center - Administrative Supplement 2025 | NIH | National Institute on Aging | 2021 to 2025 | $14,671,380 | May 1, 2020 | April 30, 2026 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $14,626,193 | May 1, 2017 | April 30, 2024 | AISEN, PAUL S. | reporter.nih.gov |
| UAB-MISS MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,601,685 | April 1, 2019 | September 30, 2026 | KEMPF, MIRJAM-COLETTE | reporter.nih.gov |
| Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,516,969 | June 1, 2022 | March 31, 2027 | ZENG, HONGKUI | reporter.nih.gov |
| Integrative Pathways to Cognitive, Affective, and Brain Health | NIH | National Institute on Aging | 2022 to 2025 | $14,488,542 | September 30, 2022 | August 31, 2028 | RYFF, CAROL D. | reporter.nih.gov |
| FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,427,244 | March 1, 2020 | December 31, 2026 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | NIH | National Institute on Aging | 2021 to 2024 | $14,414,001 | September 15, 2020 | August 31, 2025 | THOMPSON, PAUL M | reporter.nih.gov |
| Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,413,637 | April 1, 2019 | September 30, 2026 | KASSAYE, SEBLE G | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| Mild Cognitive Impairment: A Prospective Community Study | NIH | National Institute on Aging | 2021 to 2025 | $14,337,476 | September 1, 2005 | April 30, 2026 | GANGULI, MARY | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Rounds 4.2 and 4.4 | NIH | National Institute on Aging | 2021 to 2025 | $14,285,263 | September 1, 2013 | February 28, 2027 | WAITE, LINDA J | reporter.nih.gov |
| Study of Healthy Aging in African Americans | NIH | National Institute on Aging | 2023 to 2025 | $14,240,222 | January 1, 2017 | May 31, 2028 | WHITMER, RACHEL A | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2022 to 2023 | $14,187,625 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Vanderbilt Memory & Aging Project | NIH | National Institute on Aging | 2021 to 2025 | $14,019,775 | March 15, 2011 | March 31, 2027 | JEFFERSON, ANGELA L. | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| Sleep for Stroke Management And Recovery Trial (Sleep SMART) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $13,933,376 | August 15, 2018 | April 30, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| HEAL ERN: Data Coordinating Resource Center | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $13,821,158 | September 23, 2022 | August 31, 2027 | WATT, KEVIN M | reporter.nih.gov |
| Multicultural Community Dementia Screening | NIH | National Institute on Aging | 2021 to 2025 | $13,797,203 | May 1, 2021 | January 31, 2027 | GALVIN, JAMES E | reporter.nih.gov |
| Cognitive Neuroscience of Development and Aging (CoNDA) Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,774,095 | March 15, 2020 | May 31, 2030 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Wyoming Sensory Biology COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,747,906 | September 1, 2017 | July 31, 2027 | SUN, QIAN-QUAN | reporter.nih.gov |
| Arylepoxamides: A new class of potent, safer analgesics | NIH | National Institute on Drug Abuse | 2021 to 2023 | $13,729,307 | December 15, 2018 | August 31, 2025 | REICH, JEFFREY | reporter.nih.gov |
| Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $13,727,424 | September 30, 2021 | July 31, 2027 | STARRELS, JOANNA L. | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | NIH | National Institute on Drug Abuse | 2021 to 2025 | $13,649,176 | September 30, 2015 | March 31, 2027 | YURGELUN-TODD, DEBORAH A. | reporter.nih.gov |
| A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease | NIH | National Institute on Aging | 2021 | $13,634,548 | September 15, 2018 | May 31, 2024 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Center for the Study of Aphasia Recovery (C-STAR) | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $13,541,079 | April 1, 2016 | March 31, 2027 | FRIDRIKSSON, JULIUS | reporter.nih.gov |
| Lysosome Regulation and Signaling in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $13,495,371 | June 1, 2021 | February 28, 2027 | ZHENG, HUI | reporter.nih.gov |
| 1/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,466,840 | September 19, 2019 | August 31, 2025 | MEURER, WILLIAM JOSEPH | reporter.nih.gov |
| 1Florida Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $13,348,245 | June 15, 2020 | April 30, 2027 | SMITH, GLENN E. | reporter.nih.gov |
| Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP) | NIH | National Institute on Aging | 2021 to 2025 | $13,310,071 | June 1, 2021 | March 31, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $13,305,831 | July 7, 2010 | March 31, 2029 | CORESH, JOSEF | reporter.nih.gov |
| Prevention of Fractures in Patients with Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2024 | $13,269,734 | September 30, 2018 | February 28, 2026 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,208,545 | September 1, 2023 | June 30, 2028 | YENDIKI, ANASTASIA | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI) | NIH | National Institute on Aging | 2021 to 2025 | $13,167,007 | September 15, 2015 | April 30, 2026 | LEE, JINKOOK | reporter.nih.gov |
| Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,006,073 | September 25, 2019 | July 31, 2026 | CORCOS, DANIEL M. | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood | NIH | National Institute on Aging | 2023 to 2025 | $12,972,426 | September 1, 2023 | May 31, 2028 | KARIKARI, THOMAS K | reporter.nih.gov |
| The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2023 | $12,937,549 | August 15, 2016 | April 30, 2024 | SPERLING, REISA A. | reporter.nih.gov |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,902,047 | September 30, 2021 | July 31, 2026 | BECKER, WILLIAM C | reporter.nih.gov |
| Helping to End Addiction Long-term (HEAL) Data Platform | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $12,729,883 | September 1, 2025 | August 31, 2026 | GROSSMAN, ROBERT L. | reporter.nih.gov |
| THE NIH NEUROBIOBANK AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,702,242 | May 1, 2025 | October 31, 2025 | BLANCHARD, THOMAS | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project | NIH | National Institute of Mental Health | 2024 to 2025 | $12,671,179 | June 17, 2024 | May 31, 2029 | SHENTON, MARTHA E. | reporter.nih.gov |
| Tailored Retention and Engagement for Effective integrated Treatment of OUD and Pain (TREETOP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,656,947 | September 30, 2021 | July 31, 2027 | WINSTANLEY, ERIN L | reporter.nih.gov |
| Medicare at a Crossroads | NIH | National Institute on Aging | 2021 to 2025 | $12,593,170 | August 15, 2009 | April 30, 2030 | LANDON, BRUCE E. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,564,620 | September 1, 2021 | June 30, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| Duke Autism Center of Excellence: A translational digital health and computational approach to early identification, outcome monitoring, and biomarker discovery in autism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $12,545,063 | September 7, 2017 | August 31, 2027 | DAWSON, GERALDINE | reporter.nih.gov |
| Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $12,536,106 | February 15, 2022 | November 30, 2026 | MURRAY, MELISSA ERIN | reporter.nih.gov |
| Endophenotypes of Persistent Post-Concussive Symptoms in Adolescents: CARE4Kids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,522,070 | September 8, 2021 | March 31, 2027 | GIZA, CHRISTOPHER C | reporter.nih.gov |
| The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,331,452 | August 1, 2020 | July 31, 2026 | SPUDICH, SERENA S | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| Autism Center of Excellence Network: Neurodevelopmental Biomarkers of Late Diagnosis in Autism | NIH | National Institute of Mental Health | 2021 to 2025 | $12,178,377 | September 4, 2012 | June 30, 2027 | PELPHREY, KEVIN A | reporter.nih.gov |
| Exploring Cognitive Aging Using Reference Ability Neural Networks | NIH | National Institute on Aging | 2021 to 2025 | $12,167,937 | September 1, 2011 | June 30, 2027 | STERN, YAAKOV | reporter.nih.gov |
| StrokeNet Thrombectomy Endovascular Platform (STEP) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $12,112,868 | September 1, 2022 | February 28, 2026 | ELM, JORDAN J. | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Advancing brain health research through male germline editing in marmosets | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,061,296 | August 1, 2021 | May 31, 2027 | HERMANN, BRIAN PETER | reporter.nih.gov |
| A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,060,518 | September 15, 2016 | August 31, 2027 | BANKIEWICZ, KRYSTOF S | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| Alzheimers Disease Patient Registry (Administrative Supplement) | NIH | National Institute on Aging | 2021 to 2023 | $11,991,901 | September 30, 1986 | June 30, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| DIAN-TU: Next Generation Prevention Trial | NIH | National Institute on Aging | 2022 to 2023 | $11,960,034 | September 1, 2017 | May 31, 2024 | BATEMAN, RANDALL J | reporter.nih.gov |
| Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems. | NIH | National Institute on Aging | 2021 to 2025 | $11,898,685 | September 15, 2007 | May 31, 2029 | TRIVEDI, AMAL N. | reporter.nih.gov |
| I3C DECADE: Developmental Epidemiology of Childhood Cardiovascular Exposures and Alzheimer’s Dementia | NIH | National Institute on Aging | 2022 to 2025 | $11,889,015 | July 1, 2022 | April 30, 2028 | MACLEHOSE, RICHARD F | reporter.nih.gov |
| Mapping the joint-nerve interactome of the knee | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $11,877,917 | September 23, 2022 | August 31, 2027 | MALFAIT, ANNE-MARIE | reporter.nih.gov |
| Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $11,846,278 | September 1, 2024 | August 31, 2028 | OSKARSSON, BJORN E | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $11,781,095 | July 1, 2022 | June 30, 2027 | WALENSKY, LOREN DAVID | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | NIH | National Institute on Drug Abuse | 2022 to 2025 | $11,758,351 | March 11, 2024 | April 29, 2027 | MAYER, CHRISTINA | reporter.nih.gov |
| Translational Hearing Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,739,149 | March 5, 2021 | January 31, 2027 | STEYGER, PETER STEPHEN | reporter.nih.gov |
| Center for Multi-Scale Multi-Omic Human and non-human primate Brain Atlas | NIH | National Institute of Mental Health | 2025 | $11,731,574 | June 1, 2025 | May 31, 2030 | CHUNG, KWANGHUN | reporter.nih.gov |
| UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,668,134 | September 1, 2022 | August 31, 2027 | LEIN, PAMELA J | reporter.nih.gov |
| Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $11,652,217 | June 1, 2020 | March 31, 2026 | XIONG, CHENGJIE | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,639,047 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Cancer Center Support (CORE) Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,628,123 | August 1, 1997 | June 30, 2030 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| West Virginia University Stroke COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $11,604,264 | September 8, 2014 | May 31, 2026 | DEVRIES, ANNE COURTNEY | reporter.nih.gov |
| Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $11,595,410 | May 22, 2018 | May 31, 2028 | LUBY, JOAN L. | reporter.nih.gov |
| Estrogens, Cardiometabolic Health, and Female Cognitive Aging | NIH | National Institute on Aging | 2022 to 2025 | $11,521,268 | March 1, 2022 | February 28, 2027 | DANIEL, JILL M | reporter.nih.gov |
| Towards a Unified Framework for Dopamine Signaling in the Striatum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $11,510,169 | August 15, 2019 | July 31, 2025 | SABATINI, BERNARDO L | reporter.nih.gov |
| Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,497,463 | May 15, 2022 | April 30, 2027 | DONG, HONG-WEI | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population Study | NIH | National Institute on Aging | 2021 to 2025 | $11,418,675 | September 1, 2021 | May 31, 2027 | RAJAN, KUMAR B. | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| A Longitudinal Brain and Behavior Study of Autism From Infancy Through Adolescence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,410,066 | July 1, 2007 | August 31, 2027 | PIVEN, JOSEPH | reporter.nih.gov |
| Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $11,402,108 | September 30, 2004 | May 31, 2027 | BARNES, LISA L | reporter.nih.gov |
| Supplement to TR01 Human cortical development and neural plasticity altered by trisomy 21 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,380,369 | September 10, 2021 | August 31, 2027 | BHATTACHARYYA, ANITA | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| Circuit-specific cell types in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $11,340,010 | June 1, 2022 | May 31, 2028 | LEE, KUO-FEN | reporter.nih.gov |
| Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil | NIH | National Institute on Aging | 2023 to 2025 | $11,334,713 | August 15, 2023 | July 31, 2028 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Center for Mouse Genomic Variation at Single Cell Resolution | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,320,491 | August 24, 2021 | May 31, 2027 | MORTAZAVI, SEYED ALI | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| A Global Map of Interactions Among Human Cell Surface Proteins and Secreted Ligands | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $11,281,013 | September 30, 2022 | August 31, 2027 | ZINN, KAI G | reporter.nih.gov |
| DATA COORDINATING CENTER TO PROVIDE SERVICES TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM CLINICAL SITES TO PROVIDE MANAGEMENT AND DATABASE CAPABILITIES, SCIENTIFIC EXPERTISE, | NIH | National Institute on Drug Abuse | 2023 to 2025 | $11,232,511 | August 7, 2025 | August 6, 2026 | SHERMAN, SETH | reporter.nih.gov |
| The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimer’s Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,223,576 | August 15, 2004 | March 31, 2027 | JOHNSON, STERLING C | reporter.nih.gov |
| KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology | NIH | National Institute on Aging | 2021 to 2025 | $11,202,386 | August 15, 2021 | July 31, 2027 | SAYKIN, ANDREW J | reporter.nih.gov |
| Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,197,081 | September 30, 2021 | July 31, 2027 | RANA, TARIQ M | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| 5/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,114,203 | September 30, 2021 | June 30, 2026 | LIN, WEILI | reporter.nih.gov |
| Cognitive and Neurobiological Approaches to Plasticity (CNAP) Center Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,111,453 | July 15, 2017 | May 31, 2027 | BAILEY, HEATHER | reporter.nih.gov |
| From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,100,837 | September 22, 2022 | August 31, 2027 | WAINGER, BRIAN JASON | reporter.nih.gov |
| Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,085,606 | May 15, 2021 | July 31, 2026 | KENNY, PAUL J. | reporter.nih.gov |
| A Foundational Resource of Functional Elements, TF footprints and Gene Regulatory Interactions | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,067,103 | September 9, 2021 | May 31, 2026 | BUENROSTRO, JASON DANIEL | reporter.nih.gov |
| Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose | NIH | National Institute on Drug Abuse | 2022 to 2024 | $11,034,562 | February 1, 2019 | July 31, 2025 | PRAVETONI, MARCO | reporter.nih.gov |
| Center for Neural Circuits in Addiction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,925,897 | August 15, 2020 | May 31, 2030 | THOMAS, MARK JOHN | reporter.nih.gov |
| Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $10,900,445 | September 21, 2016 | May 31, 2030 | FERRARA, ASSIAMIRA | reporter.nih.gov |
| Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $10,898,840 | May 15, 2022 | April 30, 2027 | XU, XIANGMIN | reporter.nih.gov |
| A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $10,874,349 | April 1, 2019 | June 30, 2025 | FELDMAN, HOWARD | reporter.nih.gov |
| 5/21 ABCD-USA Consortium: Research Project Site at UC San Diego | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,821,558 | September 30, 2015 | March 31, 2027 | TAPERT, SUSAN F. | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Innervation of the knee and TMJ | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,814,779 | September 23, 2022 | August 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,788,004 | September 23, 2022 | July 31, 2027 | LEE, BRENDAN | reporter.nih.gov |
| HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $10,761,545 | September 23, 2022 | August 31, 2027 | BENJAMIN, DANIEL K. | reporter.nih.gov |
| Systematic identification of enhancers to target the breadth of excitatory and inhibitory neuronal cell types in the cerebral cortex | NIH | National Institute of Mental Health | 2022 | $10,679,255 | September 1, 2022 | August 31, 2025 | FISHELL, GORDON J | reporter.nih.gov |
| Phase II COBRE in Mesenchymal and Neural Regulation of Metabolic Networks | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $10,635,678 | September 1, 2017 | August 31, 2028 | LIAW, LUCY | reporter.nih.gov |
| Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis | NIH | National Institute on Aging | 2024 to 2025 | $10,584,728 | September 30, 2008 | May 31, 2029 | BATEMAN, RANDALL J | reporter.nih.gov |
| Grassroots Rigor: making rigorous research practices accessible, meaningful, and building a community around them | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,582,501 | August 1, 2022 | July 31, 2028 | KORDING, KONRAD P. | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $10,570,360 | September 9, 2021 | August 31, 2027 | BELL, THOMAS J | reporter.nih.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $10,487,739 | September 25, 2019 | August 31, 2025 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| Integrative Treatment for Achieving Holistic Recovery from Comorbid Chronic Pain and Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,475,915 | September 30, 2021 | July 31, 2027 | WITKIEWITZ, KATIE A | reporter.nih.gov |
| Mount Sinai ECHO site for Perinatal Environment and Development Studies | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $10,423,916 | September 21, 2016 | May 31, 2025 | WRIGHT, ROSALIND J | reporter.nih.gov |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| Growth and development of Striatal-Cerebellum circuitry in subjects at risk for Huntington’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,413,314 | March 1, 2009 | August 31, 2026 | NOPOULOS, PEGGY C | reporter.nih.gov |
| NIH StrokeNet National Clinical Coordinating Center (NCC) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,366,158 | September 30, 2013 | November 30, 2028 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study | NIH | National Institute on Aging | 2021 to 2024 | $10,318,677 | April 15, 2019 | January 31, 2026 | ELY, E WESLEY | reporter.nih.gov |
| 9/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U MICHIGAN | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,318,458 | September 30, 2015 | March 31, 2027 | HEITZEG, MARY M | reporter.nih.gov |
| 6/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium Vanderbilt | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,312,406 | September 30, 2021 | June 30, 2026 | CUTTING, LAURIE E | reporter.nih.gov |
| 15/21 ABCD-USA Consortium: Research Project Site at LIBR | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,302,955 | April 15, 2020 | March 31, 2027 | PAULUS, MARTIN P. | reporter.nih.gov |
| Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,302,336 | September 1, 2021 | July 1, 2025 | KHATRI, POOJA | reporter.nih.gov |
| Bridging Function, Connectivity, and Transcriptomics of Mouse Cortical Neurons | NIH | National Institute of Mental Health | 2022 to 2025 | $10,302,121 | September 1, 2022 | June 30, 2027 | ARKHIPOV, ANTON | reporter.nih.gov |
| Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa | NIH | National Institute on Aging | 2022 to 2025 | $10,293,481 | September 30, 2022 | August 31, 2027 | TOFAEONO, VAATAUSILI T | reporter.nih.gov |
| Center for Pediatric Brain Health | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $10,272,352 | March 1, 2022 | January 31, 2027 | WILSON, TONY W. | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Vermont Center for Cardiovascular and Brain Health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $10,185,844 | August 6, 2020 | May 31, 2026 | CUSHMAN, MARY | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2022 to 2023 | $10,112,651 | September 1, 2022 | June 24, 2024 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| StATins Use in intRacerebral hemorrhage patieNts (SATURN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,035,219 | September 1, 2019 | February 29, 2028 | SELIM, MAGDY H | reporter.nih.gov |
| Neuropixels NXT: Integrated Silicon Probes for Large Scale Extracellular Recording in Rodents and Primates | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $10,002,432 | September 1, 2020 | May 31, 2025 | HARRIS, TIMOTHY D | reporter.nih.gov |
| 4/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT FIU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,979,334 | September 30, 2015 | March 31, 2027 | GONZALEZ, RAUL | reporter.nih.gov |
| NEUROBIOBANK BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,962,676 | May 1, 2025 | October 31, 2025 | LEWIS, DAVID | reporter.nih.gov |
| Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility | NIH | National Institute on Aging | 2021 to 2024 | $9,901,034 | May 1, 2021 | February 28, 2026 | REDLINE, SUSAN S. | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| Gateway Exposome Coordinating Center (GECC) For AD/ADRD Research | NIH | National Institute on Aging | 2024 to 2025 | $9,887,007 | August 1, 2024 | July 31, 2029 | LEE, JINKOOK | reporter.nih.gov |
| 1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,849,650 | September 30, 2021 | June 30, 2026 | OU, XIAWEI | reporter.nih.gov |
| 5/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,809,065 | September 30, 2021 | June 30, 2026 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $9,796,602 | March 1, 2024 | February 28, 2027 | SHNEIDER, NEIL ALAN | reporter.nih.gov |
| 21/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT WUSTL | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,776,479 | April 15, 2020 | March 31, 2027 | MADDEN, PAMELA ANN | reporter.nih.gov |
| Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,737,772 | June 1, 2021 | May 31, 2027 | MORRELL, MARTHA J | reporter.nih.gov |
| Vanderbilt Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,726,538 | December 1, 1996 | March 31, 2027 | POWERS, ALVIN C | reporter.nih.gov |
| Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging) | NIH | National Institute on Aging | 2023 to 2025 | $9,673,461 | September 30, 2021 | August 31, 2027 | ROGALSKI, EMILY J | reporter.nih.gov |
| Open Platform for Online Simulations for Stimulating Peripheral Activity to Relieve Conditions - o2S2PARC | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $9,670,478 | September 22, 2017 | April 30, 2026 | KUSTER, NIELS | reporter.nih.gov |
| National Swine Resource and Research Center (NSRRC) Years 21-25 | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,635,041 | September 1, 2003 | July 31, 2028 | LEE, KIHO | reporter.nih.gov |
| TASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,613,167 | March 25, 2024 | March 24, 2026 | APPELMANS, ELINE | reporter.nih.gov |
| Defining Mechanisms of Pain Relief Associated with Dorsal Root Ganglion and Spinal Cord Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $9,610,931 | September 17, 2022 | August 31, 2027 | KOERBER, H RICHARD | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $9,598,978 | July 1, 2020 | June 30, 2030 | COX, ANDREA L | reporter.nih.gov |
| BRAIN CONNECTS: Center for Mesoscale Connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $9,562,367 | September 15, 2023 | August 31, 2028 | UGURBIL, KAMIL | reporter.nih.gov |
| 4/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,532,703 | September 30, 2021 | June 30, 2026 | MERHAR, STEPHANIE L | reporter.nih.gov |
| M-SCORCH: Methamphetamine use disorder data generation center for Single Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,490,616 | May 15, 2021 | February 28, 2027 | HO, YA-CHI | reporter.nih.gov |
| CNS Effects of Alcohol: Cellular Neurobiology | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,489,642 | December 1, 1983 | December 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| Neural Architecture of the Murine and Human Temporomandibular Joint | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $9,483,860 | September 23, 2022 | August 31, 2027 | DONNELLY, CHRISTOPHER RYAN | reporter.nih.gov |
| Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,482,559 | September 1, 2021 | August 31, 2027 | DAYEH, SHADI | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $9,464,743 | February 1, 2019 | January 31, 2026 | RAMEY, SHARON LANDESMAN | reporter.nih.gov |
| Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $9,460,610 | September 6, 2022 | August 31, 2027 | VEENSTRA-VANDERWEELE, JEREMY | reporter.nih.gov |
| 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,449,174 | September 30, 2015 | March 31, 2027 | ERNST, THOMAS M | reporter.nih.gov |
| University of Michigan (UM) HEAL Initiative National K12 Clinical Pain Career Development Program (UM-HCPDP) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $9,423,992 | September 21, 2022 | August 31, 2027 | WILLIAMS, DAVID A | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABI | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,377,344 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order | NIH | National Institute on Aging | 2021 to 2024 | $9,373,073 | June 1, 2020 | March 31, 2026 | MAYEUX, RICHARD P | reporter.nih.gov |
| Visual Sciences Center of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,360,390 | March 20, 2022 | January 31, 2027 | RAMAMURTHY, VISVANATHAN | reporter.nih.gov |
| A novel therapeutic to ameliorate chronic pain and reduce opiate use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $9,323,255 | March 15, 2019 | June 30, 2024 | TABAKOFF, BORIS | reporter.nih.gov |
| Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) DCC | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,319,090 | September 1, 2023 | August 31, 2028 | COFFEY, CHRISTOPHER S. | reporter.nih.gov |
| Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT) | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $9,296,510 | January 15, 2025 | December 31, 2026 | KAPUR, JAIDEEP | reporter.nih.gov |
| The San Antonio Heart and Mind Study | NIH | National Institute on Aging | 2023 to 2025 | $9,286,743 | July 1, 2023 | March 31, 2029 | SATIZABAL, CLAUDIA L | reporter.nih.gov |
| Human Nociceptor and Spinal Cord Molecular Signature Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $9,264,871 | September 19, 2022 | August 31, 2027 | PRICE, THEODORE J. | reporter.nih.gov |
| African Americans Fighting Alzheimer’s in Midlife (AA-FAIM) | NIH | National Institute on Aging | 2021 to 2025 | $9,250,399 | August 1, 2016 | November 30, 2027 | GLEASON, CAREY E | reporter.nih.gov |
| Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimer’s disease pathogenesis in the BEACoN Cohort | NIH | National Institute on Aging | 2021 to 2025 | $9,240,061 | August 1, 2017 | December 31, 2027 | YASSA, MICHAEL A | reporter.nih.gov |
| Cell type atlasing of whole human brains using HOLiS: an optimized pipeline for staining, clearing, imaging, and analysis | NIH | National Institute of Mental Health | 2021 | $9,121,879 | September 22, 2021 | September 21, 2025 | HILLMAN, ELIZABETH M. C. | reporter.nih.gov |
| GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $9,120,320 | September 6, 2022 | August 31, 2027 | VOLK, HEATHER E | reporter.nih.gov |
| 7/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,118,437 | September 30, 2021 | June 30, 2026 | VOLK, HEATHER E | reporter.nih.gov |
| Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $9,111,057 | July 1, 2019 | April 30, 2027 | SHETH, KEVIN NAVIN | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Center of Excellence in Environmental Toxicology | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $9,096,433 | April 1, 2006 | May 31, 2030 | PENNING, TREVOR M | reporter.nih.gov |
| HEALthy Brain and Child Development Study at UAB and UA | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,071,052 | September 30, 2021 | June 30, 2026 | NEWSOM, CASSANDRA R. | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| University of New Mexico (UNM) Center for Brain Recovery and Repair | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $9,061,444 | September 15, 2015 | June 30, 2026 | SHUTTLEWORTH, CLAUDE W | reporter.nih.gov |
| Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers | NIH | National Institute on Drug Abuse | 2023 to 2025 | $9,048,057 | September 30, 2023 | August 31, 2026 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease | NIH | National Institute of Mental Health | 2023 to 2025 | $9,005,480 | August 23, 2023 | August 22, 2026 | HADIJAH, VACTOR | reporter.nih.gov |
| Epidemiologic Study of Neural Reserve and Neurobiology of Aging | NIH | National Institute on Aging | 2021 to 2023 | $8,995,869 | September 30, 2001 | May 31, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | NIH | National Institute on Aging | 2021 to 2025 | $8,986,759 | June 1, 2020 | August 31, 2030 | JOFFE, HADINE | reporter.nih.gov |
| Prevention Research Center: Parenting Among Women Who Are Opioid Users | NIH | National Institute on Drug Abuse | 2021 to 2023 | $8,972,150 | August 15, 2019 | May 31, 2025 | LEVE, LESLIE DIANE | reporter.nih.gov |
| BRAIN CONNECTS: Comprehensive Regional Projection Map of Marmoset with Single Axon and Cell Type Resolution | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $8,970,238 | September 7, 2023 | August 31, 2028 | FENG, GUOPING | reporter.nih.gov |
| TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,957,809 | August 30, 2023 | August 29, 2026 | ROTH, BRYAN | reporter.nih.gov |
| Consequences of Incarceration on Health, Age-Related Conditions, and Risk Factors for ADRD | NIH | National Institute on Aging | 2024 to 2025 | $8,887,003 | August 15, 2024 | April 30, 2029 | TEPLIN, LINDA A | reporter.nih.gov |
| Molecular and Circuit Pathogenesis of Alcohol Use Disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,884,347 | December 1, 1997 | November 30, 2027 | KASH, THOMAS L. | reporter.nih.gov |
| Biospecimen Exchange for Neurological Disorders (BioSEND) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,861,360 | August 1, 2021 | July 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| Experimental and Clinical Studies of Presbyacusis Extension and Supplement | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $8,845,880 | July 1, 1997 | July 31, 2026 | DUBNO, JUDY R | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| 23/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,838,592 | September 30, 2021 | June 30, 2026 | ROGERS, CYNTHIA ELISE | reporter.nih.gov |
| Translational Platform for Epilepsy Therapy and Biomarker Discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,833,081 | April 15, 2022 | March 31, 2027 | GALANOPOULOU, ARISTEA S | reporter.nih.gov |
| Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,810,103 | September 21, 2016 | May 31, 2030 | O'SHEA, MICHAEL | reporter.nih.gov |
| 7/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT YALE | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,739,227 | September 30, 2015 | March 31, 2027 | BASKIN-SOMMERS, ARIELLE RYAN | reporter.nih.gov |
| Medical Scientist Training Program (T32 NRSA Training Grant) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $8,724,805 | July 1, 2021 | June 30, 2026 | KAO, AIMEE | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Risk Factors, Pathology, and Clinical Expressions of AD | NIH | National Institute on Aging | 2021 to 2024 | $8,703,055 | July 15, 1998 | April 30, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $8,683,509 | September 30, 2022 | July 31, 2025 | TOLL, LAWRENCE R | reporter.nih.gov |
| Tools for gene editing in marmosets | NIH | National Institute on Drug Abuse | 2022 to 2025 | $8,672,011 | September 1, 2022 | June 30, 2027 | WANG, XIAOQIN | reporter.nih.gov |
| 19/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UVM | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,669,646 | April 15, 2020 | March 31, 2027 | GARAVAN, HUGH P. | reporter.nih.gov |
| Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Human Genotype-Tissue Expression Project | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,668,711 | September 22, 2021 | June 30, 2027 | SESTAN, NENAD | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| K-CORE: Curation and Knowledge Management for SPARC | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $8,626,284 | September 4, 2020 | September 3, 2026 | MARTONE, MARYANN E | reporter.nih.gov |
| Revisiting ReCHARGE: ECHO Follow up on Middle Childhood and Adolescence | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,577,337 | September 21, 2016 | May 31, 2030 | HERTZ-PICCIOTTO, IRVA | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2023 to 2024 | $8,554,832 | May 15, 2019 | February 28, 2026 | WARREN, JOHN ROBERT | reporter.nih.gov |
| P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India | NIH | National Institute on Aging | 2024 to 2025 | $8,548,820 | September 15, 2024 | August 31, 2029 | NARAYAN, KABAYAM M VENKAT | reporter.nih.gov |
| Alzheimer variants: Propagation of shared functional changes across cellular networks | NIH | National Institute on Aging | 2021 to 2025 | $8,542,236 | July 15, 2021 | June 30, 2027 | DE JAGER, PHILIP L | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $8,481,225 | September 1, 2022 | August 31, 2027 | AMIN, RAOUF S. | reporter.nih.gov |
| Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,480,887 | September 30, 2019 | April 30, 2027 | GRIGSON, PATRICIA SUE | reporter.nih.gov |
| Preserving Cognitive Resilience: A Biracial Parent-Offspring Study | NIH | National Institute on Aging | 2022 to 2024 | $8,461,054 | March 1, 2019 | May 31, 2026 | RAJAN, KUMAR B. | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Genetic Architecture of Alzheimer’s disease Proteinopathies | NIH | National Institute on Aging | 2021 to 2024 | $8,376,544 | April 15, 2021 | February 28, 2026 | KAMBOH, M. ILYAS | reporter.nih.gov |
| Genetic Studies of Alzheimer's Disease in Jewish and Arab Populations | NIH | National Institute on Aging | 2023 to 2025 | $8,372,205 | September 1, 2023 | August 31, 2028 | FARRER, LINDSAY A. | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,345,645 | September 10, 2022 | July 31, 2027 | SAFFORD, MONIKA M | reporter.nih.gov |
| EPPIC-NET DCC - Supplement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $8,306,997 | September 1, 2023 | August 31, 2025 | TROXEL, ANDREA B | reporter.nih.gov |
| ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA | NIH | National Institute on Aging | 2022 to 2025 | $8,306,361 | June 15, 2022 | March 31, 2027 | MESULAM, MAREK-MARSEL M | reporter.nih.gov |
| Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies | NIH | National Institute on Aging | 2021 to 2025 | $8,305,058 | July 1, 2021 | June 30, 2026 | MONTINE, THOMAS J | reporter.nih.gov |
| 3/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U MINNESOTA | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,298,588 | September 30, 2015 | March 31, 2027 | LUCIANA, MONICA | reporter.nih.gov |
| Exceptional Longevity Data Management and Coordinating Center | NIH | National Institute on Aging | 2022 to 2025 | $8,296,806 | September 1, 2022 | July 31, 2027 | VARMA, SUSHEEL | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| MRI Based Presymptomatic Prediction of ASD | NIH | National Institute of Mental Health | 2021 to 2024 | $8,292,562 | March 16, 2024 | January 31, 2026 | PRUETT, JOHN R | reporter.nih.gov |
| Washington University Intellectual and Developmental Disabilities Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,281,463 | July 28, 2020 | May 31, 2027 | DOUGHERTY, JOSEPH D | reporter.nih.gov |
| 6/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT OHSU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,270,799 | September 30, 2015 | March 31, 2027 | NAGEL, BONNIE J. | reporter.nih.gov |
| Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,267,463 | September 1, 2022 | August 31, 2026 | THOMAS, ROBERT JOSEPH | reporter.nih.gov |
| Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials | NIH | National Institute on Drug Abuse | 2022 | $8,267,350 | September 30, 2022 | September 29, 2025 | PRAVETONI, MARCO | reporter.nih.gov |
| Sex-based Differences in Glioma | NIH | National Cancer Institute | 2021 to 2025 | $8,258,328 | September 14, 2020 | December 31, 2026 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $8,257,593 | September 26, 2019 | August 31, 2025 | ANSTROM, KEVIN J | reporter.nih.gov |
| Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials | NIH | National Institute on Aging | 2021 to 2023 | $8,244,109 | February 1, 2019 | January 31, 2025 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,243,787 | August 15, 2021 | June 30, 2027 | FOX, HOWARD S | reporter.nih.gov |
| The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,227,499 | September 1, 2021 | August 31, 2027 | PHATNANI, HEMALI | reporter.nih.gov |
| COBRE in Stroke Recovery Administrative Supplement - Team Science | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $8,212,817 | June 2, 2014 | March 31, 2025 | KAUTZ, STEVEN A. | reporter.nih.gov |
| GLASS-AD: Global Latinos Sequencing Study for Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $8,212,071 | September 30, 2023 | August 31, 2028 | TOSTO, GIUSEPPE | reporter.nih.gov |
| Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,210,604 | February 1, 2016 | July 31, 2027 | ROSAND, JONATHAN | reporter.nih.gov |
| Tailored Non-Pharmacotherapy Services for Chronic Pain: Testing Scalable and Pragmatic Approaches - Admin Supplement | NIH | National Institute on Aging | 2021 to 2023 | $8,205,902 | September 30, 2019 | August 31, 2025 | DEBAR, LYNN L. | reporter.nih.gov |
| A BRAIN Initiative Resource: The Neuroscience Multi-omic Data Archive | NIH | National Institute of Mental Health | 2021 to 2025 | $8,199,148 | September 15, 2017 | June 30, 2027 | WHITE, OWEN R | reporter.nih.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,178,365 | September 30, 2019 | August 31, 2026 | KAMPMAN, KYLE MATTHEW | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| 14/21 ABCD-USA Consortium: Research Project Site at CU Boulder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,148,103 | April 15, 2020 | March 31, 2027 | BANICH, MARIE T | reporter.nih.gov |
| Breaking the Cycle of Intergenerational Disadvantage: Neurodevelopment Among Puerto Rican Children | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $8,132,278 | September 21, 2016 | August 31, 2023 | DUARTE, CRISTIANE S. | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial | NIH | National Institute on Aging | 2021 to 2022 | $8,118,116 | April 1, 2017 | September 30, 2024 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations | NIH | National Institute on Aging | 2021 to 2024 | $8,105,276 | June 1, 2020 | March 31, 2026 | ANTONUCCI, TONI CLAUDETTE | reporter.nih.gov |
| A Community Resource for Single Cell Data in the Brain | NIH | National Institute of Mental Health | 2022 to 2025 | $8,097,786 | September 1, 2022 | June 30, 2027 | HAWRYLYCZ, MICHAEL | reporter.nih.gov |
| The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order Phenotypes | NIH | National Institute of Mental Health | 2021 to 2022 | $8,086,271 | September 5, 2018 | June 30, 2023 | KROGAN, NEVAN J | reporter.nih.gov |
| An extensible brain knowledge base and toolset spanning modalities for multi-species data-driven cell types | NIH | National Institute of Mental Health | 2022 to 2025 | $8,067,240 | September 1, 2022 | June 30, 2027 | MUFTI, SHOAIB | reporter.nih.gov |
| Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2025 | $8,050,699 | April 1, 2021 | January 31, 2027 | CRAWFORD, GREGORY E | reporter.nih.gov |
| Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries | NIH | National Institute on Aging | 2024 to 2025 | $8,032,655 | September 30, 2024 | August 31, 2029 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| NeuroExplorer: Ultra-high Performance Human Brain PET Imager for Highly-resolved In Vivo Imaging of Neurochemistry | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $8,011,666 | September 12, 2020 | August 31, 2025 | CARSON, RICHARD E. | reporter.nih.gov |
| Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $8,002,252 | September 23, 2022 | August 31, 2027 | AKOPIAN, ARMEN N | reporter.nih.gov |
| Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project | NIH | National Institute on Aging | 2022 to 2025 | $7,983,648 | June 1, 2022 | May 31, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | NIH | National Institute of Mental Health | 2022 to 2025 | $7,973,681 | February 1, 2022 | November 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation | NIH | National Institute of Mental Health | 2021 to 2024 | $7,968,668 | February 1, 2020 | April 24, 2025 | GOLDSTEIN, JILL M | reporter.nih.gov |
| Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,961,338 | September 30, 2019 | August 31, 2030 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| 14/24 The Healthy Brain & Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,959,706 | September 30, 2021 | June 30, 2027 | BANDOLI, GRETCHEN E. | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,941,988 | September 30, 2024 | August 31, 2027 | REICH, JEFFREY | reporter.nih.gov |
| RACE-CARS CCC 1/2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,922,259 | July 1, 2020 | June 30, 2027 | GRANGER, CHRISTOPHER B. | reporter.nih.gov |
| 20/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT VCU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,897,207 | April 15, 2020 | March 31, 2027 | BJORK, JAMES M | reporter.nih.gov |
| 4/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,886,572 | September 30, 2021 | June 30, 2026 | KABLE, JULIE A | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,874,666 | August 15, 2024 | December 31, 2027 | FRANCE, CHARLES P | reporter.nih.gov |
| 2/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,856,113 | September 30, 2021 | June 30, 2026 | LEVITT, PAT | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,828,464 | September 1, 2015 | May 31, 2027 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| 16/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,814,498 | September 30, 2021 | June 30, 2026 | FOX, NATHAN A | reporter.nih.gov |
| Restoring Vision with High-Fidelity Nonsense Codon Correction | NIH | National Eye Institute | 2021 to 2025 | $7,812,597 | February 1, 2021 | November 30, 2026 | PATTNAIK, BIKASH RANJAN | reporter.nih.gov |
| ERICH-GENE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,768,356 | August 1, 2010 | June 30, 2025 | DEMEL, STACIE | reporter.nih.gov |
| The POINTER Neurovascular Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $7,761,498 | April 15, 2020 | December 31, 2025 | BRINKLEY, TINA E | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $7,746,716 | September 15, 2021 | August 31, 2028 | BOGNER, JENNIFER A | reporter.nih.gov |
| Reexamining the Role of Dendrites in Neuronal Function | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $7,740,604 | August 1, 2023 | July 31, 2028 | YUSTE, RAFAEL | reporter.nih.gov |
| 3/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,734,571 | September 30, 2021 | June 30, 2026 | HUANG, HAO | reporter.nih.gov |
| PURPOSE: Positively Uniting Researchers of Pain to Opine, Synthesize, and Engage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $7,732,800 | September 28, 2022 | March 21, 2025 | COVERSTONE, JACOB SUTTON | reporter.nih.gov |
| Mapping the vulnerable locus coeruleus pathways in aging and AD | NIH | National Institute on Aging | 2022 to 2025 | $7,731,727 | August 15, 2022 | July 31, 2027 | CHUNG, KWANGHUN | reporter.nih.gov |
| Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $7,715,052 | August 15, 2020 | July 31, 2025 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| Transition from Acute to Chronic Pain After Thoracic Surgery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $7,656,419 | August 1, 2020 | July 31, 2024 | BRUMMETT, CHAD M | reporter.nih.gov |
| SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging | NIH | National Institute on Aging | 2021 to 2025 | $7,600,838 | May 1, 2020 | April 30, 2027 | JAGUST, WILLIAM J. | reporter.nih.gov |
| Vietnamese Insights into Cognitive Aging Program (VIP) | NIH | National Institute on Aging | 2021 to 2025 | $7,598,841 | February 15, 2021 | May 31, 2026 | MEYER, OANH L | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,571,345 | December 1, 1996 | December 31, 2027 | KAHN, STEVEN EMANUEL | reporter.nih.gov |
| Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia | NIH | National Institute on Aging | 2023 to 2025 | $7,564,979 | September 15, 2023 | May 31, 2028 | GALAMA, TITUS JOHANNES | reporter.nih.gov |
| ACE-D: Accelerating Cognition-guided signatures to Enhance translation in Depression | NIH | National Institute of Mental Health | 2024 to 2025 | $7,556,428 | May 3, 2024 | February 28, 2029 | WILLIAMS, LEANNE | reporter.nih.gov |
| 8/24 The Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,554,291 | September 30, 2021 | June 30, 2026 | THOMASON, MORIAH E | reporter.nih.gov |
| THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITE(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,530,975 | May 1, 2025 | October 31, 2025 | SCOTT, WILLIAM | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| A major contributor of serious multisystem disease in the elderly: varicella zoster virus-induced inflammation | NIH | National Institute on Aging | 2021 to 2023 | $7,526,233 | March 1, 2009 | December 31, 2025 | NAGEL, MARIA ACENA | reporter.nih.gov |
| Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 | $7,523,227 | September 15, 2022 | August 31, 2025 | SHADYAB, ALADDIN | reporter.nih.gov |
| REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $7,516,765 | January 1, 2022 | December 31, 2027 | ZIAI, WENDY C | reporter.nih.gov |
| Pediatric Dose Optimization for Seizures in EMS (PediDOSE) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $7,509,102 | August 1, 2021 | November 30, 2023 | SHAH, MANISH ISHWAR | reporter.nih.gov |
| Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $7,501,613 | August 15, 2019 | July 31, 2025 | SLUKA, KATHLEEN A | reporter.nih.gov |
| Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE) | NIH | National Institute on Aging | 2021 to 2025 | $7,489,463 | March 1, 2021 | February 28, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $7,486,964 | February 15, 2020 | January 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients | NIH | National Institute on Aging | 2021 to 2022 | $7,416,643 | September 15, 2020 | May 31, 2023 | MOEBIUS, HANS JOERG | reporter.nih.gov |
| Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience | NIH | National Institute on Aging | 2021 to 2024 | $7,413,273 | September 15, 2020 | May 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2023 to 2024 | $7,403,993 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 905 | $1.41 billion | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 795 | $1.26 billion | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 856 | $1.26 billion | 0 | $0 |
| Washington University | Saint Louis, MO | 764 | $1.23 billion | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 761 | $1.17 billion | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 709 | $1.13 billion | 0 | $0 |
| Yale University | New Haven, CT | 717 | $1.10 billion | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 692 | $989.8 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 642 | $973.2 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 739 | $963.2 million | 0 | $0 |
| Stanford University | Stanford, CA | 698 | $871.2 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 382 | $813.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 529 | $797.8 million | 0 | $0 |
| Emory University | Atlanta, GA | 507 | $710.6 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 589 | $705.9 million | 0 | $0 |
| Duke University | Durham, NC | 542 | $647.9 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 373 | $638.9 million | 0 | $0 |
| University of Washington | Seattle, WA | 503 | $621.8 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 456 | $613 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 460 | $603 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 437 | $584.3 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 360 | $526.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 441 | $494 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 297 | $485.9 million | 0 | $0 |
| University of California at Davis | Davis, CA | 369 | $476.9 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 398 | $476.7 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 325 | $463.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 253 | $458.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 387 | $415.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 207 | $412.9 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 303 | $402 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 296 | $380.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 228 | $377.2 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 341 | $371.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 206 | $363.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 285 | $356 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 295 | $343.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 366 | $340.6 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 262 | $327.3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 273 | $321.3 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 223 | $317.8 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 193 | $308.5 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 268 | $304.7 million | 0 | $0 |
| Allen Institute | Seattle, WA | 48 | $298 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 186 | $292.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 278 | $290.5 million | 0 | $0 |
| University of Rochester | Rochester, NY | 265 | $273.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 244 | $257.7 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 208 | $251.4 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 168 | $241.1 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 169 | $239.7 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 250 | $237.1 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 210 | $232.7 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 189 | $230.1 million | 0 | $0 |
| University of Chicago | Chicago, IL | 174 | $229.1 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 194 | $218.7 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 274 | $214.6 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 200 | $210 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 96 | $209 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 150 | $208.6 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 86 | $205.2 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 143 | $203.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 130 | $203.6 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 119 | $196 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 148 | $193.9 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 57 | $192.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 159 | $184.6 million | 0 | $0 |
| Brown University | Providence, RI | 175 | $184.4 million | 0 | $0 |
| Harvard University | Cambridge, MA | 100 | $182.2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 178 | $180 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 110 | $173.6 million | 0 | $0 |
| Public Health Institute | Oakland, CA | 4 | $171.7 million | 0 | $0 |
| New York University | New York, NY | 165 | $162.4 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 94 | $154.6 million | 0 | $0 |
| University of South Florida | Tampa, FL | 101 | $152.2 million | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 125 | $148.2 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 49 | $147.1 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 117 | $145.3 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 154 | $143.8 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 114 | $143.7 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 64 | $139.3 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 113 | $137.2 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 145 | $135.7 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 96 | $135.7 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 32 | $135.5 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 144 | $135.3 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 144 | $129.8 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 124 | $123.2 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 98 | $121.1 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 116 | $120.4 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 81 | $119.5 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 100 | $119.1 million | 0 | $0 |
| Massachusetts Eye and Ear Infirmary | Boston, MA | 77 | $116.2 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 106 | $112.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 129 | $112.4 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 81 | $111.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 57 | $110.2 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 68 | $107.8 million | 0 | $0 |
| Columbia University | New York, NY | 95 | $105.2 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 65 | $103.5 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 16,326 | $10,277,293,767 | 0 | $0 |
| 2024 | 17,702 | $10,129,447,077 | 0 | $0 |
| 2023 | 17,736 | $10,229,635,070 | 0 | $0 |
| 2022 | 17,645 | $9,795,037,874 | 0 | $0 |
| 2021 | 16,974 | $9,155,559,480 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.